Abstract Purpose of Review Without effective antimicrobials, patients cannot undergo
transplant surgery safely or sustain immunosuppressive therapy. This review examines the …

Enterobacteriaceae; ESBL, extended-spectrum beta-lactamase; EUCAST, European
Committee on Antimicrobial Susceptibility Testing; FDA, Food and Drug Administration; ICU …

Liver transplant (LT) recipients are vulnerable to infections with multidrug‐resistant (MDR)
pathogens. Risk factors for colonization and infection with resistant bacteria are ubiquitous …

Advances in surgical techniques and immunosuppressive agents have made solid organ
transplant (Tx) an important strategy for treatment of end-stage organ failures. However, the …

Antimicrobial therapies are essential tools for transplant recipients who are at high risk for
infectious complications. However, judicious use of antimicrobials is critical to preventing the …

Abstract Purpose of Review Carbapenem-resistant Enterobacteriaceae (CRE) have
emerged as a worldwide problem. Given their degree of immunosuppression and the level …

The advancements in surgical techniques, immunosuppressive therapies, and infection
control and prophylaxis, along with significant changes in the policy of graft recruitment and …

Background The consequences of inappropriate antimicrobial use including resistance are
increasingly recognized as a global public health threat and many steps have been taken …

Solid organ transplant (SOT) recipients are especially at risk of developing infections by
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …

Bacteria are the leading cause of infections after solid organ transplantation. In recent years,
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …